Log in to save to my catalogue

A Case of 123 I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developi...

A Case of 123 I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35956242

A Case of 123 I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene

About this item

Full title

A Case of 123 I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene

Publisher

Switzerland

Journal title

Journal of clinical medicine, 2022-08, Vol.11 (15)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

Pheochromocytoma (PCC) is rare catecholamine-producing endocrine tumor that metastasizes in approximately 10% of cases. As a functional imaging of PCC, 123I-metaiodobenzylguanidine (MIBG) scintigraphy was established, and some cases of PCC exhibit negative accumulation on MIBG scintigraphy, indicating a high risk of metastasis. Additionally, germli...

Alternative Titles

Full title

A Case of 123 I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_35956242

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35956242

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm11154624

How to access this item